SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

Share Price is delayed by 15 minutes
Get Live Data
4,612.00    26.00 (0.57%)
Bid:
4,610.00
Ask:
4,614.00
Spread: 4.00 (0.087%)
Market Cap: £16.81b
CCH Live PriceLast checked at - London Stock Exchange

Intraday Coca-Cola HBC Share Chart

Transaction in Own Shares

14 Jan 2019 07:09

RNS Number : 9802M
Coca-Cola HBC AG
14 January 2019
 

FOR IMMEDIATE RELEASE

 

Coca-Cola HBC AG

Transaction in own shares

 

Zug, Switzerland - 14 January 2019 - Coca-Cola HBC AG ("Company") announces that it purchased the following number of its ordinary shares of 6.70 CHF each ("ordinary shares") on the London Stock Exchange through Credit Suisse Securities (Europe) Limited ("Credit Suisse") as part of its share purchase programme announced on Monday 3 December 2018:

 

Date of transaction

11 January 2019

Number of shares repurchased

70,000

Average price paid per share

2516.22 pence

Lowest price paid per share

2499.00 pence

Highest price paid per share

2552.00 pence

Broker

Credit Suisse

 

The repurchased ordinary shares will be either cancelled upon receiving approval from the Company's shareholders and subsequent implementation of a capital decrease or be used to meet the requirements of the Company's employee incentive scheme. Until such approval is obtained or the shares are used to meet such requirements, the repurchased ordinary shares will be held in treasury.

 

As at 14 January 2019, the Company's issued share capital consisted of 371,827,229 ordinary shares, of which 1,321,938 ordinary shares are held by Coca-Cola HBC AG (including the repurchased shares) and 3,430,135 ordinary shares are held by its subsidiary, Coca-Cola HBC Services MEPE, in treasury. Therefore the total number of voting rights in the Company is 367,075,156 which may be used by shareholders as the denominator for calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

Since announcing the share purchase programme on Monday 3 December 2018, the Company has purchased 1,307,013 of its ordinary shares.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), a full breakdown of the transactions made by Credit Suisse on behalf of the Company as part of the share purchase programme is attached to this announcement.

 

http://www.rns-pdf.londonstockexchange.com/rns/9802M_1-2019-1-14.pdf

 

 

Enquiries

Coca‑Cola HBC Group

Maria Livaniou

Head of shareowner services

 

Tel: +30 210 6183 106

 maria.livaniou@cchellenic.com

 

 

 

 

About Coca‑Cola HBC

Coca-Cola HBC is a leading bottler of The Coca-Cola Company with an annual sales volume of more than 2 billion unit cases. It has a broad geographic footprint with operations in 28 countries serving a population of approximately 600 million people. Coca-Cola HBC offers a diverse range of primarily non-alcoholic ready-to-drink beverages in the sparkling, juice, water, sport, energy, tea and coffee categories. Coca-Cola HBC is committed to promoting sustainable development in order to create value for its business and for society. This includes providing products that meet the beverage needs of consumers, fostering an open and inclusive work environment, conducting its business in ways that protect and preserve the environment and contribute to the socio-economic development of the local communities. Coca-Cola HBC has been listed in the Dow Jones Sustainability Indices since 2008, and ranked among the top beverage companies in the Global and European indices for the past four years. Coca-Cola HBC is also included in the FTSE4Good Index, rated "AAA" on the MSCI ESG index, rated "A" for Climate and Water by CDP and listed on the Sustainalytics and Vigeo rankings.

 

Coca-Cola HBC has a premium listing on the London Stock Exchange (LSE: CCH) and its shares are listed on the Athens Exchange (ATHEX: EEE). For more information, please visit http://www.coca-colahellenic.com.

 

 

Important notice relating to Credit Suisse

Credit Suisse, which is regulated by the Financial Conduct Authority in the UK, is acting exclusively for the Company and no one else in connection with the matters set out in this announcement and will not be responsible to any person other than the Company for providing the protections afforded to clients of Credit Suisse, nor for providing advice in relation to the content of this announcement or any matter referred to herein. Neither Credit Suisse nor any of its subsidiaries, branches or affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Credit Suisse in connection with this announcement, any statement contained herein or otherwise.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
POSUSRBRKNAAARR
Date   Source Headline
19th Mar 20251:00 pmRNSDirector/PDMR Shareholding
18th Mar 20251:21 pmRNSDirector/PDMR Shareholding
14th Mar 20253:45 pmRNSAnnual Financial Report
13th Mar 20252:18 pmRNSDirector/PDMR Shareholding
12th Mar 20259:22 amRNSDirector/PDMR Shareholding
11th Mar 202512:17 pmRNSDirector Declaration
5th Mar 20251:19 pmRNSDirector/PDMR Shareholding
4th Mar 20256:03 pmRNSTransfer of treasury shares and voting rights
4th Mar 20254:03 pmRNSDirector/PDMR Shareholding
26th Feb 202510:07 amRNSDirector/PDMR Shareholding
18th Feb 20251:50 pmRNSDirector/PDMR Shareholding
17th Feb 20259:22 amRNSDirector/PDMR Shareholding
13th Feb 20257:00 amRNSStrong execution drove continued profitable growth
3rd Feb 202510:09 amRNSTransfer of treasury shares and voting rights
27th Jan 20253:13 pmRNSCorrection - Total voting rights
20th Jan 20251:49 pmRNSDirector/PDMR Shareholding
15th Jan 20251:55 pmRNSNotice of Results
3rd Jan 202511:51 amRNSTotal Voting Rights
2nd Jan 20259:16 amRNSDirector/PDMR Shareholding
18th Dec 20242:19 pmRNSDirector/PDMR Shareholding
17th Dec 20244:17 pmRNSDirector/PDMR Shareholding
17th Dec 20244:09 pmRNSDirector/PDMR Shareholding
17th Dec 20243:46 pmRNSHolding(s) in Company
4th Dec 202410:50 amRNSDirector/PDMR Shareholding
4th Dec 202410:28 amRNSDirector/PDMR Shareholding
2nd Dec 202410:35 amRNSTotal Voting Rights
29th Nov 20241:40 pmRNSDirector/PDMR Shareholding
29th Nov 202410:08 amRNSDirector/PDMR Shareholding
28th Nov 20248:41 amRNSDirector/PDMR Shareholding
28th Nov 20248:23 amRNSDirector/PDMR Shareholding
19th Nov 20243:51 pmRNSDirector/PDMR Shareholding
19th Nov 202411:14 amRNSFinal Terms - 2032 Notes
13th Nov 20244:41 pmRNSDirector Declaration
13th Nov 20244:11 pmRNSPricing of Issue of Notes
13th Nov 20248:39 amRNSIssue of Debt
12th Nov 20243:56 pmRNSPublication of Suppl.Prospcts
8th Nov 202410:27 amRNSNotice of purchase
7th Nov 202411:39 amRNSDirector/PDMR Shareholding
7th Nov 202411:36 amRNSDirector/PDMR Shareholding
1st Nov 202410:12 amRNSBlock listing Interim Review
31st Oct 20247:00 amRNSStrong execution drives continued growth
18th Oct 20243:36 pmRNSDirector/PDMR Shareholding
8th Oct 20241:06 pmRNSCCH holds webinar on Data, Insights and Analytics
4th Oct 20248:40 amRNSNotice of Results
1st Oct 20249:42 amRNSTotal Voting Rights
27th Sep 20245:17 pmRNSTransaction in Own Shares
26th Sep 20245:08 pmRNSTransaction in Own Shares
25th Sep 20245:06 pmRNSTransaction in Own Shares
23rd Sep 20245:05 pmRNSTransaction in Own Shares
20th Sep 20245:21 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.